ExpreS2ion Biotech Holding AB (EXPRS2) — Tangible Net Worth Ratio
ExpreS2ion Biotech Holding AB (EXPRS2) has a Tangible Net Worth Ratio of 94.7% as of March 2026. This metric is calculated by deducting intangible assets (Skr1.41 Million) from net assets (Skr26.42 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset momentum of ExpreS2ion Biotech Holding AB to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
ExpreS2ion Biotech Holding AB Tangible Net Worth Ratio (2013–2025)
This chart shows how ExpreS2ion Biotech Holding AB's Tangible Net Worth Ratio has changed across 11 annual periods from 2013 to 2025. As of March 2026, the ratio stands at 94.7%, reflecting net assets of Skr26.42 Million with intangible assets of Skr1.41 Million SEK. For live market cap and overall valuation, see ExpreS2ion Biotech Holding AB (EXPRS2) total market value.
Annual Tangible Net Worth Ratio for ExpreS2ion Biotech Holding AB (2013–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for ExpreS2ion Biotech Holding AB from 2013 to 2025, covering 11 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore reinvestment intensity of ExpreS2ion Biotech Holding AB to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (SEK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 95.8% | Skr35.69 Million | Skr1.50 Million | Skr65.11 Million | ▼ -1.0 pp |
| 2024 | 96.8% | Skr64.42 Million | Skr2.08 Million | Skr104.53 Million | ▲ +0.6 pp |
| 2023 | 96.2% | Skr65.36 Million | Skr2.47 Million | Skr78.69 Million | ▼ -0.9 pp |
| 2022 | 97.1% | Skr103.33 Million | Skr2.95 Million | Skr137.36 Million | ▼ -0.6 pp |
| 2021 | 97.8% | Skr140.35 Million | Skr3.14 Million | Skr151.96 Million | ▲ +1.9 pp |
| 2020 | 95.9% | Skr94.55 Million | Skr3.91 Million | Skr118.86 Million | ▲ +80.6 pp |
| 2018 | 15.3% | Skr8.30 Million | Skr7.03 Million | Skr20.95 Million | ▲ +37.6 pp |
| 2017 | -22.3% | Skr6.74 Million | Skr8.24 Million | Skr17.23 Million | ▼ -48.9 pp |
| 2016 | 26.5% | Skr12.88 Million | Skr9.46 Million | Skr24.61 Million | ▼ -73.5 pp |
| 2014 | 100.0% | Skr2.35 Million | Skr0.00 | Skr5.48 Million | ▲ +0.0 pp |
| 2013 | 100.0% | Skr1.93 Million | Skr0.00 | Skr4.11 Million | — |